The Patient Characteristics and Mortality of Code Blue Calls
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02203435|
Recruitment Status : Completed
First Posted : July 29, 2014
Last Update Posted : August 6, 2014
This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2009 and 2013.
Primary outcome: an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2009-2013.Secondary outcome: to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.Inclusion criteria: patients throughout the whole hospital for whom a Code Blue form was completed and who were evaluated by the Code Blue team on a Code Blue call.
Exclusion criteria: patients who refused treatment
|Condition or disease|
|Demographics of the Patients Evaluated by Code Blue Call|
|Study Type :||Observational|
|Actual Enrollment :||1050 participants|
|Official Title:||The Characteristics of the Blue-code Calls; Five Years Survey.|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||April 2014|
|Actual Study Completion Date :||April 2014|
- mortality of blue-codes [ Time Frame: 5 years ]an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2009-2013.
- the demographics of blue code admissions [ Time Frame: 5 years ]to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.
- the rate of successful cardiopulmonary resuscitation [ Time Frame: 5 years ]the rate of CPR, the apache and saps II expanded values and indication of ICU stay will be calculated
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02203435
|Istanbul Umraniye Education and Research Hospital|
|Istanbul, Turkey, 34760|
|Study Director:||Nurten Bakan, assoc prof||Istanbul Umraniye Education and Research Hospital|